scholarly article | Q13442814 |
P356 | DOI | 10.1177/0961203307084170 |
P698 | PubMed publication ID | 18042586 |
P50 | author | Yehuda Shoenfeld | Q1515807 |
Eiji Matsuura | Q73476759 | ||
P2093 | author name string | Kobayashi K | |
Yasuda T | |||
Ueno T | |||
Tsutsumi A | |||
de Groot PG | |||
Kuwana M | |||
Tada K | |||
Itabe H | |||
Liu PH | |||
P2860 | cites work | Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells | Q24307173 |
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. | Q27619832 | ||
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity | Q28344371 | ||
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man | Q28359675 | ||
THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM | Q29391553 | ||
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies | Q33225081 | ||
i.v.IG for autoimmune, fibrosis, and malignant conditions: our experience with 200 patients | Q33360957 | ||
Intravenous immunoglobulins control scleromyxoedema | Q34486310 | ||
Immunomodulatory action of intravenous immunoglobulin. | Q35013334 | ||
SLE, atherosclerosis and cardiovascular disease | Q36135534 | ||
IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients | Q36205447 | ||
Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 | ||
Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis | Q36514385 | ||
Oxidized phosphatidylcholines that modify proteins. Analysis by monoclonal antibody against oxidized low density lipoprotein | Q36838426 | ||
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma | Q37358413 | ||
Normal polyspecific immunoglobulin G (IVIg) in the treatment of autoimmune diseases | Q40738864 | ||
Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface | Q42084495 | ||
Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols | Q43545513 | ||
Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation | Q43823942 | ||
Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages | Q44138798 | ||
Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen | Q44300088 | ||
Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the Fc portion | Q44513069 | ||
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. | Q46095021 | ||
Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. | Q50847890 | ||
Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus | Q58190397 | ||
P433 | issue | 12 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 929-938 | |
P577 | publication date | 2007-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages | |
P478 | volume | 16 |
Q37143021 | Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice |
Q37190468 | Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. |
Q37378106 | Atherosclerosis in autoimmune diseases |
Q37606350 | Autoimmunity, infectious immunity, and atherosclerosis |
Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
Q37318786 | Oxidative modification of LDL: its pathological role in atherosclerosis |
Q36671159 | Pathophysiological mechanisms in antiphospholipid syndrome |
Q37721597 | Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome |
Q37328097 | Pentraxins, anti-pentraxin antibodies, and atherosclerosis |
Q58802965 | Pro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex |
Q28553042 | Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect |
Q37173369 | Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques. |
Q34644753 | The inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE−/− mice |
Q33575750 | The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice. |
Search more.